Search results
Results from the WOW.Com Content Network
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies (such as insect bites) and asthma. [1] [2] Immunotherapy involves exposing people to larger and larger amounts of allergens in an attempt to change the immune system's response.
The Chihuahua has some genetic predisposition to several neurological diseases, among them atlantoaxial instability, ceroid lipofuscinosis, congenital deafness, congenital hydrocephalus, muscular dystrophy, necrotizing meningoencephalitis, and neuroaxonal dystrophy; [20]: 3 [21] it has a mild predisposition to congenital heart disease.
Signs are similar to human disease, including anorexia, fever, and thrombocytopenia. [12] Clostridium species can cause diarrhea in dogs. Associated species include C. perfringens and Clostridioides difficile. [13] Kennel cough is an infectious respiratory disease that can be caused by one of several viruses or by Bordetella bronchiseptica. It ...
There are certain conditions that chihuahua owners should be aware of. This breed can be prone to dental disease and a condition called luxating patellas. This condition causes the kneecaps to ...
Chihuahuas can have two different head shapes: apple or deer. ... Folklore from bygone times suggests that Chihuahuas were able to cure various respiratory ailments, such as asthma and other ...
"Chihuahua boy mom here… to see a male vet doctor being nurturing and patient with this little fella warms my heart. You’re an angel," someone else praised. "Now this is a man who is ...
However complex human diseases can often be better understood in a simplified system in which individual parts of the disease process are isolated and examined. For instance, behavioral analogues of anxiety or pain in laboratory animals can be used to screen and test new drugs for the treatment of these conditions in humans. A 2000 study found ...
The TSLP signaling axis is an attractive therapeutic target. Amgen's Tezepelumab, a monoclonal antibody which blocks TSLP, is currently approved for the treatment of severe asthma. [30] [31] Fusion proteins consisting of TSLPR and IL-7Rα which can trap TSLP with excellent affinity have also been designed. [22]